ITPKB suppresses ER calcium release to promote CXCL9 expression and enhance immunotherapy sensitivity in triple-negative breast cancer

Drug Resistance Updates · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles